Log in to save to my catalogue

Serum NR1 and NR2 concentrations in first-episode schizophrenia and clinical high-risk for psychosis

Serum NR1 and NR2 concentrations in first-episode schizophrenia and clinical high-risk for psychosis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b02e8fc4201445a29a27be72c64aa415

Serum NR1 and NR2 concentrations in first-episode schizophrenia and clinical high-risk for psychosis

About this item

Full title

Serum NR1 and NR2 concentrations in first-episode schizophrenia and clinical high-risk for psychosis

Publisher

England: BioMed Central Ltd

Journal title

BMC psychiatry, 2025-05, Vol.25 (1), p.493-9, Article 493

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

This study evaluated the utility of serum NR1 and NR2 concentrations in identifying individuals with first-episode schizophrenia (FES) and clinical high risk (CHR) as well as their correlations with clinical symptoms and cognitive domains.
This cross-sectional study compared peripheral blood NR1 and NR2 concentrations among the FES, CHR, and hea...

Alternative Titles

Full title

Serum NR1 and NR2 concentrations in first-episode schizophrenia and clinical high-risk for psychosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b02e8fc4201445a29a27be72c64aa415

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b02e8fc4201445a29a27be72c64aa415

Other Identifiers

ISSN

1471-244X

E-ISSN

1471-244X

DOI

10.1186/s12888-025-06950-w

How to access this item